spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Repros Therapeutics 

 HSMN NewsFeed - 10 Apr 2017
Repros Names Larry Dillaha, M.D., its Permanent President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2016
Repros Requests Meeting With FDA to Discuss Phase 3 Requirements for Proellex(R) in the Treatment of Endometriosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Feb 2013
Repros Therapeutics Corporate Update
Biopharmaceuticals FDA Personnel
 HSMN NewsFeed - 3 Jan 2012
Donald Tredway MD, PhD, Joins Repros as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2010
FDA Lifts Full Clinical Hold on Repros' Proellex(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2010
Repros Receives Guidance From FDA Regarding Clinical Hold Status of Proellex(R)
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2009
Repros Appoints Dr. Jaye Thompson to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Nov 2009
Mirna Therapeutics Appoints Dr. Paul Lammers as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Sep 2009
Repros Therapeutics Inc. Provides Update on Proellex
Biopharmaceuticals
 HSMN NewsFeed - 25 Jul 2007
Repros Reports That Patients Exposed to Proellex For Up To Six Months Demonstrated A Benign Endometrium Based On Biopsy
Biopharmaceuticals
 HSMN NewsFeed - 5 Jul 2007
Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Dec 2006
Repros' Androxal Shows Noninferiority in Interim Phase 3 Analysis
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2006
Repros Announces Appointment of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2006
Repros Reports Proellex Achieves Statistically Significant Pain Reduction in Endometriosis Trial
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2006
Repros Reports Partial Interim Assessment of Phase 2 Study of Proellex(TM) in Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
Repros Therapeutics Provides Update for Ongoing Clinical Studies
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 1 additional stories matching:
Repros Therapeutics
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.